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ABSTRACT 
 
Ribonuclease (RNase) P is a ribonucleoprotein complex that is responsible for cleaving 
the 5' leader sequence during the maturation of tRNA molecules. Its three-dimensional structure 
yet unknown, RNase P in human nuclei is thought to contain ten protein subunits and one RNA 
subunit. In contrast, RNase P in the hyperthermophilic archaeon Pyrococcus furiosus (Pfu) is 
simpler, with only five protein subunits and one RNA subunit. Though the three-dimensional 
structure of the archaeal holoenzyme is also unknown, all five protein subunits are homologous 
to corresponding subunits in human RNase P. Due to its more tractable configuration, yet 
maintained homology, analysis of Pfu RNase P is attractive as a model to provide insights into 
the structure and function of the human enzyme. The long-term goal of this project is to develop 
an atomic-resolution model of the Pfu RNase P holoenzyme. To aid in structure determination of 
this ribonucleoprotein complex, the attachment of an ethylenediaminetetraacetic acid (EDTA) 
moiety to strategically-located cysteine residues on one of the protein subunits was explored in 
order to exploit the EDTA moiety’s metal-chelating capabilities in two distinct ways. The 
chelation of paramagnetic Mn2+ allowed for the execution of paramagnetic relaxation 
enhancement (PRE) nuclear magnetic resonance (NMR) experiments. This unconventional NMR 
method enables distance restraints to be obtained over larger distances than conventional NMR 
methods. The chelation of iron atoms allowed for the implementation of RNA footprinting 
experiments by utilizing Fe·EDTA-generated hydroxyl radicals: the hydroxyl radicals cleave 
nucleic acid in a distance-dependent manner. Thus, preparation of chelator-tagged proteins was 
shown to provide valuable information to constrain structural models of the Pfu RNase P 
holoenzyme. 
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INTRODUCTION 
 
RNase P 
 
Ribonuclease (RNase) P is an endoribonuclease that is responsible for catalyzing the 
essential cleavage reaction to remove the 5’-leader sequence from precursor transfer ribonucleic 
acid (ptRNA) molecules [1-3]. Discovered by Dr. Sidney Altman in 1970, RNase P is found in 
all three phylogenetic domains of life: bacteria, archaea, and eukarya [2, 4]. Altman later 
determined that RNase P from Escherichia coli (E. coli) contains a catalytic RNA core, for 
which he was subsequently awarded the 1989 Nobel Prize in Chemistry, along with Dr. Thomas 
Cech, for this discovery that RNA can act as a biocatalyst [5]. RNase P is essentially required for 
life; there are only a few known organisms that lack RNase P [6]. Moreover, RNase P exists 
almost universally as a ribonucleoprotein; one noteworthy exception is human mitochondrial 
RNase P, which functions as a protein enzyme [7]. In addition to processing ptRNAs, RNase P 
has also been shown to cleave messenger RNA transcripts, polycistronic tRNA, precursor 4.5S 
RNA, precursor tmRNA, and certain riboswitches [8-11].  
Despite its prevalence across the three domains of life, this ribozyme exhibits varied 
structural composition. In general, more complex organisms contain a greater number of RNase 
P proteins (RPPs) than do simpler organisms: in bacteria, RNase P exists as the RNase P RNA 
(RPR) subunit in complex with one RPP. In archaea, the RPR is joined by at least four RPPs, and 
eukaryotes have the RPR and at least nine RPPs [12]. This pattern of increasing protein content 
in more evolutionarily complex organisms suggests that RNase P is perhaps a partial holdover 
from the RNA world [13]. 
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The Rationale for Studying RNase P from Pyrococcus furiosus 
 
 While certain functions of RNase P have already been illuminated, the overall structure 
of the ribonucleoprotein complex in higher organisms has yet to be determined. Given the 
essential role of RNase P in processing ptRNA, structural differences between the human version 
and RNase P in pathogenic organisms could provide an attractive avenue for antimicrobial 
chemotheraphy [14]. Therefore, solving RNase P structures could provide useful insights for 
such drug development, as well as elucidate how the ribozyme functions at an atomic level. The 
hyperthermophilic archaeon Pyrococcus furiosus (Pfu), an anaerobic heterotroph that was 
originally isolated from geothermal vents in Italy, provides a tractable system that also maintains 
homology with the human enzyme [15]. Though the bacterial ribonucleoprotein complex is 
simplest in composition, with only one RPP joining the RNA subunit, none of the archaeal or 
eukaryal RPPs possesses appreciable sequence homology to the bacterial RPP. Pfu RNase P, in 
contrast, is composed of five RPPs that are all homologous to RPPs in human nuclear RNase P, 
and reconstitution of eukaryal RNase P remains challenging [16, 17].  
The five RPPs in Pfu are homologs of the human nuclear RNase P proteins RPP21, 
RPP29, RPP30, POP5, and RPP38/L7Ae. From these, two heterodimeric pairs are formed in 
solution: one between RPP21 and RPP29 and one between POP5 and RPP30 [18, 19]. 
Representative structures of each of these proteins have been determined by nuclear magnetic 
resonance (NMR) spectroscopy and x-ray crystallography from the hyperthermophilic archaea 
Pyrococcus horikoshii (Pho), Methanocaldoccus jannaschii (Mja), or Pfu [20-24]. Furthermore, 
the structures of the RPP21-RPP29 complex and of the POP5-RPP30 complex have been 
determined [18, 25]. The Pfu RPR contains two separately-folding domains [26] and is 
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homologous to the bacterial A-type RPR [27], but details of its three-dimensional structure are 
not yet known. 
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APPROACH 
EPD Reaction and the Selection of Metal Ions 
 
With the knowledge that substantial structural information is already available about 
structures of components of Pfu RNase P, the purpose of this study is to implement a method to 
provide structural information on the overall organization of subunits in the Pfu RNase P 
holoenzyme. The strategy employed involves the strategic attachment of an 
ethylenediaminetetraacetic acid (EDTA) moiety to engineered cysteine residues on mutant 
versions of one of the protein subunits. The EDTA moiety can chelate an array of transition 
metals and thus facilitate certain structural measurements. Specifically, EDTA-2-aminoethyl 2-
pyridyl disulfide (EPD) has previously been used to attach metal ions to cysteine residues 
(Figure 1) in order to provide protein-nucleic acid and protein-protein structural information 
(including information from bacterial RNase P) [28-34]. RPP29 was selected as the initial 
protein target for the addition of the EDTA moiety because, at the time, the interface of the 
RPP21-RPP29 heterodimer in solution was in need of refinement and these experiments had the 
potential to provide additional structural information in an effort to improve the accuracy of the 
structural model [Xu and Foster, unpublished]. Manganese(II) (Mn2+) was chosen as one of the 
metals to chelate with the EDTA moiety because it is paramagnetic and can therefore enable 
paramagnetic relaxation enhancement (PRE) NMR experiments [34]. Iron(III) (Fe3+) was also 
selected because of EDTA-Fe’s ability to generate hydroxyl radicals, which can cleave nucleic 
acid in a distance-dependent manner and therefore facilitate RNA footprinting assays with the 
RPR and the RPPs [28-30]. EDTA binds both Mn2+ and Fe3+ tightly: the respective Kds are    
~10-11 M and ~10-21 M [35]. 
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PRE NMR and the Generation of Distance Restraints 
 
 The nuclei of certain atoms (isotopes), such as those from 1H and 15N, have magnetic 
dipoles. When exposed to an external magnetic field (such as that provided by the 
superconducting magnet of an NMR spectrometer), these magnetic dipoles can be thought of as 
assuming one of two orientations where each orientation is associated with a unique energy 
level. Irradiating these nuclei with pulses of electromagnetic radiation in the radio-wave range 
can cause their magnetic dipoles to transition between energy levels. The postulates of quantum 
mechanics dictate that these transitions to an excited state occur only if the energy (frequency) of 
the electromagnetic radiation matches the energy difference between the transitional states. It is 
these transitions that give rise to observable NMR signals [36]. 
A nucleus in an excited state can be manipulated to expel the excitation (magnetization) 
to other nuclei, and the resonance frequency of each nucleus through which the magnetization is 
passed can be measured in an NMR experiment. Signals that link the frequencies of each of 
those nuclei can be obtained, and such correlation spectra allow for the unambiguous assignment 
of a signal to its corresponding nuclei [36]. 
The NMR data included in this study are heteronuclear single-quantum coherence 
(HSQC) spectra, in which signals arise from through-bond correlation between each 1H-15N 
bonded pair in the protein. Each of these signals is a sensitive probe of the local chemical 
environment that surrounds the 1H-15N pair. Among other uses, the 15N-HSQC experiment is 
helpful in determining whether a protein is folded or whether a series of mutations has 
dramatically altered the tertiary structure of a protein [36]. In other words, the 15N-HSQC 
spectrum can provide a high-resolution “fingerprint” of the protein [35]. 
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As opposed to the HSQC NMR experiment, 2D nuclear Overhauser effect spectroscopy 
(NOESY) experiment can correlate two protons if they are within 5-6 Å of each other through 
space [36]. These correlations can provide useful short-range structural information and are the 
principal structural measurement in NMR-based structure determination of proteins. 
Paramagnetic relaxation enhancement (PRE) NMR experiments can provide complementary 
longer-range structural information (up to 35 Å for a Mn2+-1H interaction) [38]. During 
relaxation of an NMR signal, magnetization is lost as the excited states of the nuclei lose 
enthalpy or gain entropy [37]. In PRE experiments performed with Mn2+, such as in this study, 
the introduction of a Mn2+ ion to a system causes an enhancement of these nuclear relaxation 
processes due to through-space interactions with the large magnetic moment of the unpaired 
Mn2+ electrons [37]. Therefore, intensities of NMR signals that arise from sites near the Mn2+ ion 
decrease in a quantifiable, distance-dependent manner. If these signals are well separated and 
have been assigned to individual positions in the molecule, distances from the NMR nuclei to the 
paramagnetic probe can be calculated from the reduced intensity. 
 
RNA Footprinting and the Fenton Reaction 
 
Whereas PRE NMR experiments can provide valuable structural information, they are 
limited by the requirement of assigned, well-resolved NMR signals. However, the same 
functionalized proteins used for PRE NMR can be used to provide protein-RNA structural 
information in footprinting experiments that lead to RNA cleavage in the vicinity of the metal 
probe. The Fenton reaction was utilized to complete the RNA footprinting experiments [39]. 
EDTA-Fe creates hydroxyl radicals from water molecules when it is in the presence of ascorbate 
and hydrogen peroxide and has previously been used to obtain high-resolution structural 
information about the E. coli RNase P holoenzyme [30]. In this study, the Pfu RPR was 
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incubated alongside the EDTA-Fe moiety and was cleaved in a distance-dependent manner by 
the hydroxyl radicals. Reverse-transcribed complementary DNA (cDNA) fragments partially 
synthesized with radiolabeled dideoxynucleoside triphosphates (ddNTPs) were then subjected to 
polyacrylamide gel electrophoresis and visualized by autoradiography, thus indicating the 
cleavage site on the RNA [30]. 
 
Single-cysteine Mutants and the Selection of Sites 
 
To ensure precise placement of the EDTA moiety, it is useful to have only one cysteine 
residue per protein. Wild type RPP21 has a zinc atom that is bound by four cysteine residues and 
this interaction helps to stabilize the protein’s tertiary structure [40, 18]. Therefore, RPP29 
provided a better target for the modification reaction because its cysteine residue was deemed to 
be less essential to the structure and function of the protein. In RPP29, the wild-type cysteine is 
located at residue 94 and is buried in the interior of the protein when RPP29 forms its native 
complex with RPP21 [18]. Modifying surface-exposed residues in the native structural 
conformation is preferred to modifying buried residues because surface residues are more easily 
accessed by the EPD reagent. Additionally, the EDTA moiety from EPD is hydrophilic and the 
modification of surface residues would likely perturb the overall structure less than would the 
modification of buried residues.  
The native cysteine was therefore mutated to alanine and a library of single-cysteine 
mutants was eventually developed [Xu and Foster, unpublished]. These mutants included 
R75C/C94A (henceforth known as R75C) and K88C/C94A (henceforth known as K88C), among 
others. Positively-charged amino acids were targeted as the sites of cysteine mutation due to their 
relatively high probability of being near or in the protein-RNA binding interface; due to the 
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distance-dependent manner of hydroxyl cleavage, positioning the EDTA-Fe moiety near the 
protein-RNA interface is vital if cleavage of the RNA is desired. 
Prior to the PRE NMR and the RNA footprinting experiments, it was important to 
perform activity assays to ensure that the modification of the RPP29 proteins did not render the 
proteins non-functional. In these assays performed by members of the Gopalan laboratory, the 
Pfu holoenzyme was reconstituted and incubated with radiolabeled ptRNA substrate. After 
incubation, reaction products were run on a polyacrylamide gel and visualized with a 
phosphorimager to quantify the reconstituted enzyme activities. 
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MATERIALS AND METHODS 
Generation of a Single-cysteine Library 
 
Mutant pET-33b(+) plasmids encoding the Pfu RPP29 gene under control of the T7 
promoter, and resistant to the antibiotic kanamycin, were engineered via QuikChange 
mutagenesis and verified by DNA sequencing [Xu and Foster, unpublished]. 
 
Expression of RPP29 
 
RPP29 proteins were produced based on procedures described in [18]. For all of the 
RPP29 mutants, the plasmid of interest was transformed by electroporation into E. coli 
BL21(DE3) Rosetta cells (Novagen), a bacterial strain that expresses rare tRNAs from a plasmid 
that encodes resistance to the antibiotic chloramphenicol. Lysogeny broth (LB) was then added 
and the cells were incubated at 37 °C for one hour before being plated on an LB/agar plate that 
contained the antibiotics kanamycin (30 µg/L) and chloramphenicol (34 µg/L). After incubation 
at 37 °C for 12-16 hours, a single colony was harvested from the plate and placed in a starter 
culture containing 100 mL of LB, 30 µg/L of kanamycin, and 34 µg/L of chloramphenicol. This 
starter culture was shaken at 250 rotations per minute (RPM) for 12 hours at 37 °C. Afterwards, 
12.5 mL of the starter culture was added to each of two 500-mL solutions of LB broth in 2-L 
Erlenmeyer flasks (with 30 µg/L of kanamycin and 34 µg/L of chloramphenicol). These 
Erlenmeyer flasks were shaken at 250 RPM and 37 °C until the OD600 reached 0.6. (For protein 
to be labeled with 15N instead of LB media, two 500-mL solutions of minimal media, each 
containing 3.3 g anhydrous Na2HPO4, 1.5 g KH2HPO4, 0.25 g NaCl, and 0.5 g 15NH4Cl, were 
placed in 2-L Erlenmeyer flasks. 5 mL of the starter culture was then added to each of the flasks 
with minimal media and shaken at 250 RPM and 37 °C until the OD600 reached 0.6.) At this 
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point, 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to both flasks to induce 
protein expression and the flasks were shaken at 250 RPM and 37 °C for four hours. Cells were 
then harvested by centrifugation at 6,084 g and 15 °C for 10 minutes. 
 
Purification of RPP29 Derivatives 
 
Aqueous buffers used during the purification: 
    
Native Buffer Resuspension Buffer 
25 mM Tris-HCl, pH 7.5 25 mM Tris-HCl, pH 7.5 
1 mM EDTA 1 mM EDTA 
0.1 mM PMSF*# 0.1 mM PMSF* 
50 mM Dithiothreitol (DTT)* 50 mM DTT* 
0.02 % NaN3 7 M Urea 
 0.02 % NaN3 
   
Buffer A1 Buffer B1 
25 mM Tris-HCl, pH 7.0 25 mM Tris-HCl, pH 7.0 
25 mM KCl 2 M KCl 
10 mM DTT* 10 mM DTT* 
7 M Urea 7 M Urea 
0.02 % NaN3 0.02 % NaN3 
 
* = freshly added (just before use) 
# = phenylmethanesulfonylfluoride 
 
The cell pellets from the two 500-mL cultures were combined and resuspended in 30 mL 
of Native Buffer and then lysed by sonication on ice [five second pulse, two second rest, six 
minutes, 65 watts]. These lysed cells were then centrifuged at 7,649 g and 15 °C for 15 minutes. 
The pellet from this centrifugation step was then resuspended in 30 mL of Resuspension Buffer 
and sonicated on ice [five second pulse, two second rest, six minutes, 65 watts]. After 
centrifugation at 7,649 g and 15 °C for 15 minutes, the supernatant was filtered (0.45 µm) and 
then passed through a 5-mL SP cation-exchange column previously equilibrated with 25 mL of 
Resuspension Buffer (with 10 mM DTT and 1 mM PMSF). This SP column was then attached to 
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a fast protein liquid chromatography (FPLC) instrument with Buffer A1 and Buffer B1. In the 
first segment of the elution gradient, the composition of the elution buffer changed from 0 % 
Buffer B1 to 10 % Buffer B1 over five column volumes (CVs). During the second segment of 
the gradient, the composition of the elution buffer changed from 10 %B to 25 %B over 10 CVs. 
During the third segment of the gradient, the composition of the elution buffer changed from 25 
% Buffer B1 to 100 % Buffer B1 over two CVs. During the final segment of the gradient, the 
composition of the elution buffer was 100 % Buffer B1. The protein typically eluted at a KCl 
concentration of about 300 mM, corresponding to an elution buffer composition of about 14 % 
Buffer B1. Using this protocol, the R75C and K88C proteins were expressed and purified. 
 
EPD Modification Reaction to Prepare NMR Samples 
 
First, 10 mM DTT was added to the sample of protein to be modified to ensure reduction 
of the cysteine residues. This protein solution was then passed through a PD-10 desalting column 
(GE Healthcare) into a buffer with 10 mM Tris, 10 mM KCl, 0.02 % NaN3, and pH 8.0. Each 
pass through a PD-10 column dilutes the protein concentration by a factor of 5/7 because 2.5 mL 
of protein sample are loaded into the column and 3.5 mL are used to elute. After determining the 
concentration of the protein in solution by using its predicted extinction coefficient at 280 nm 
[41], EPD was added to the solution in five-fold excess over the protein concentration. This 
solution was then passed through another PD-10 column into a buffer with 10 mM Tris, 10 mM 
KCl, 0.02 % NaN3, and pH 8.0. Manganese(II) (as manganous sulfate) was then added in a five-
fold excess over the protein concentration. Excess manganese was finally removed by using a 
HiTrap Desalting Column (Sigma-Aldrich) connected to the FPLC machine to exchange the old 
buffer for one with 10 mM Tris, 10 mM KCl, 0.02 % NaN3, and pH 8.0. The protein sample 
(RPP29-EDTA-Mn2+) was then concentrated by ultrafiltration with a 3-kDa molecular weight 
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cutoff membrane (Amicon) in preparation for the NMR experiments. Final protein 
concentrations ranged from 172 µM to 315 µM. 
 
EPD Modification Reaction to Prepare Samples for RNA Footprinting 
 
EPD was reacted with a 10-fold excess of FeCl3 in water that had been run through a 
Chelex-100 column. Protein cysteine residues were reduced by addition of 10 mM DTT to the 
sample of protein to be modified. A three-step dialysis procedure into a 1000-mL solution with 
10 mM Tris, 10 mM KCl, 0.02 % NaN3, and pH 8.0 was performed on the ~2-mL protein 
samples, with each step lasting one hour. After the last step of the dialysis procedure, the 
previously-prepared EPD-Fe3+ was added in a 10-fold excess to the concentrations of the RPP29 
mutants. These modified protein samples were then stored at 4 °C until being used for the 
footprinting assays. 
 
Quantification of the Extent of EPD Modification 
 
Ellman’s reagent (Pierce Biotechnology); 5,5’-dithio-bis-(2-nitrobenzoic acid) (DTNB); 
which quantifies the concentration of free thiol groups in solution, was used to quantify the 
extent of the EPD modification (Figure 2) [42, 43]. The reaction of DTNB with cysteine thiol 
groups is monitored by observing the production of 2-nitro-5-thiobenzoic acid (TNB), which has 
an extinction coefficient of 14,150 M-1cm-1 at 412 nm. The reaction was carried out in a buffer 
with 10 mM Tris, 10 mM KCl, 0.02 % NaN3, and pH 8.0. A standard curve that plotted the 
absorbance of 412 nm light against the concentration of various stock solutions of cysteine was 
generated and used to determine thiol concentrations (data not shown). 
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Preparation of NMR Samples 
 
Concentrated, uniformly-15N-labeled K88C-EDTA ([U-15N]-K88C-EDTA) and [U-15N]-
K88C-EDTA-Mn2+ species were generated as outlined above. Afterward, 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) was added in a five-fold excess over the protein concentration 
and deuterium oxide (D2O) was added to 5% (v/v). The sample was then loaded into a reduced-
volume NMR tube (Shigemi, Inc.) and stored at 4 °C. 
 
Acquisition of NMR Data 
 
NMR spectra were recorded at 53 °C on an 800 MHz Bruker Avance DRX spectrometer 
(Billerica, MA) located on the main campus of The Ohio State University and equipped with 
triple resonance pulse-field gradient probes. NMR data were processed and analyzed with 
NMRPipe and NMRViewJ [44, 45]. The resulting spectra were compared to the assigned 15N-
HSQC spectrum of the wild type RPP29 protein [46]. 
 
Activity and Footprinting Assays 
 
Results of RNase P activity assays and hydroxyl radical-mediated footprinting studies 
were obtained in the Gopalan laboratory by Cecilia Go and Dr. Lien Lai, respectively. RPP29-
EDTA-Fe3+ (K88C-EDTA-Fe3+, for example) was generated as outlined above. This modified 
RPP29 protein was reconstituted with the other Pfu RNase P subunits, including the RPR, and 
then incubated with labeled ptRNA substrate. Activity of each mutant was determined by the 
initial reaction velocities. For the footprinting assays, modified RPP29 was incubated with RPR 
and introduced to ascorbate and hydrogen peroxide to promote the formation of hydroxyl 
radicals [30]. Radiolabeled, reverse-transcribed cDNA fragments were then run on a 
polyacrylamide gel and used to map cleavage sites to the RPR. 
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RESULTS 
Single-cysteine mutants of R75C and K88C were over-expressed in E. coli and then 
purified. After reacting K88C protein with EPD, an assay with Ellman’s reagent showed that 
greater than 98% of the cysteine residues had been modified by EPD (Table 1). Additionally, 
K88C, K88C-EDTA, and K88C-EDTA-Mn2+ species were analyzed by electrospray ionization 
(ESI) mass spectrometry to verify their identities (Figure 4). Interestingly, the mass spectra 
showed evidence of protein carbamylation, which is commonly seen if old or previously-heated 
solutions of urea are used in protein purifications [46-48]. Cyanate ions resulting from urea 
degradation can react with lysine residues to form homocitrulline, a chemical modification that 
would result in a protein mass increase of 43 Daltons (Da). Moreover, the three most-abundant 
peak distributions in panel (B) of Figure 4 show evidence of metal contamination: the 
distribution with a mass-to-charge (m/z) ratio centered around 15,245.06 is likely the K88C-
EDTA species, whose expected average mass is 15,245.5 Da. The peak distribution with an m/z 
ratio centered around 15,306.96 could correspond to K88C-EDTA species that had chelated a 
transition metal with an approximate mass of 62 Da. Examples of such metals include cobalt 
(~59 Da), nickel (~59 Da), copper (~64 Da), and zinc (~65 Da). Therefore, this peak distribution 
could contain many different metals that were chelated by the K88C-EDTA species prior to the 
introduction of manganese. For completeness, the peak distribution with an m/z ratio centered 
around 15,349.97 could represent the K88C-EDTA species that was both modified by cyanate 
and contaminated with a transition metal. 
In preparation for the NMR experiments, the K88C mutant of RPP29 (uniformly labeled 
with 15N) was over-expressed in E. coli and then purified with a yield of approximately 115 mg 
per liter of minimal media (Figure 3). Purified [U-15N]-K88C was then modified with EPD 
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(resulting in [U-15N]-K88C-EDTA) and then mixed with Mn2+ to generate the [U-15N]-K88C-
EDTA-Mn2+ species. Figures 5-8 show NMR spectra of wild type [U-15N]-RPP29, [U-15N]-
C94A, [U-15N]-K88C/C94A (“K88C”), [U-15N]-K88C/C94A-EDTA (“K88C-EDTA”), and [U-
15N]-K88C-EDTA-Mn2+ (K88C-EDTA-Mn2+). The NMR experiments involving the [U-15N]-
K88C-EDTA and [U-15N]-K88C-EDTA-Mn2+ species examined the effects of adding Mn2+ to 
the protein sample. Residues whose peaks showed the highest sensitivity to the PRE probe were 
mapped to the structure of Pfu RPP29 based on assignments for the C94A mutant (Figure 9): 
residues V64, Y63, T74, V86, W87, V89, and K91 were found to be most broadened. 
In preparation for the RNA footprinting experiments, unlabeled K88C protein was over-
expressed in E. coli and then purified with a yield of approximately 80 mg per liter of LB (Figure 
10). The R75C mutant was also over-expressed and purified in the same manner. Both proteins 
were then modified with EPD-Fe that had previously been mixed to generate the respective 
RPP29-EDTA-Fe3+ species. The K88C and K88C-EDTA-Fe3+ species were subjected to analysis 
by matrix assisted laser desorption/ionization (MALDI) mass spectrometry to verify their 
respective identities (Figure 11).  Precursor tRNA cleavage assays were used to check the 
activity of the RPP29 mutants in the context of the complete holoenzyme (data not shown). RNA 
footprinting assays were then performed on both RPP29 mutants and reverse-transcribed cDNA 
fragments from the assays were run on a polyacrylamide gel (Figure 12). After analyzing the 
polyacrylamide gel, the cleavage sites were mapped to the primary and secondary structures of 
the RPR (Figure 13). Modified R75C and K88C mutants were shown to footprint on P9 of the 
Pfu RPR; cleavage sites from the footprinting assays were in regions of the RPR that have 
previously been predicted to bind RPP29 [18]. 
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Discussion 
 In preparation for the PRE NMR experiments, K88C was successfully purified from 
BL21(DE3) Rosetta cells and was relatively straightforward. The EDP modification reaction, 
however, proved to be somewhat complicated. K88C, being a single-cysteine mutant of RPP29, 
can assemble covalent dimers by forming disulfide bonds. Since the thiol groups on the cysteine 
residues are necessary for the EPD modification reaction, it is important to limit the formation of 
these inter-protein disulfide bonds by using a reducing agent (such as dithiothreitol, DTT). In a 
type of Catch-22, the reducing DTT species cannot be present during the modification reaction, 
or else it will cleave the disulfide bond on DTNB and also reduce any disulfide bonds formed as 
a result of the EPD modification reaction. It should further be noted that the longer RPP29 is in 
solution in a reduced form under oxidizing conditions (i.e., without reducing agents), the more 
inter-protein disulfide bonds it will form; protein oxidation has been shown to be spontaneous 
[50].  
Therefore, to overcome this challenge, protein reduction by DTT, followed by three rapid 
rounds of dialysis to remove the DTT, was first attempted. This technique was met with little 
success: the EPD reagent would react (as determined by Ellman’s reagent) repeatedly in excess 
of the known protein concentration (as determined by UV-Vis spectroscopy and the protein’s 
predicted extinction coefficient at 280 nm), suggesting residual DTT contamination. As an 
alternative to dialysis, PD-10 desalting columns allowed for the rapid removal of DTT and 
enabled the EPD modification reaction to attach the EDTA moiety to RPP29. 
 To verify the successful addition of the EDTA moiety to the RPP29 mutants, a number of 
methods were examined. The extinction coefficient of 2-pyridylthiol, the leaving group from the 
EPD modification reaction, is known at 343 nm and could hypothetically be used to monitor the 
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progress of the modification reaction [51]. However, simply reporting on the cleavage of the 
disulfide bond in EPD, as this assay would do, would not ensure that the EDTA moiety has been 
properly attached to the cysteine residues of interest. Therefore, in addition to monitoring the 
progress of the modification reaction at 343 nm, two additional verification methods were 
employed. First, Ellman’s reagent was used to check the concentration of free thiol species in 
solution after the EPD modification reaction. This test would detect any unreacted cysteine 
residues, so ideally Ellman’s reagent would report no free thiol groups in solution after the 
reaction.  
As the second method of verifying the successful attachment of the EDTA moiety, two 
forms of mass spectrometry (ESI and MALDI) were employed. ESI analysis of K88C samples 
resulted in some interesting mass spectra. All three spectra show evidence of lysine 
carbamylation, a phenomenon commonly encountered if protein samples have been purified with 
old urea or urea that has been heated [47-49]. Incidentally, the buffers with urea that were used 
for that purification of RPP29 were nine months old at the time of the purification and had been 
accidentally boiled while being made. In addition to this lysine carbamylation, however, there 
was also evidence of metal contamination.  
NMR experiments were performed on the [U-15N]-K88C-EDTA and [U-15N]-K88C-
EDTA-Mn2+ species and resulted in the mapping of signals affected by PRE to residues on 
RPP29. Protein degradation was observed for the [U-15N]-K88C-EDTA sample after 16 days, a 
result that is consistent with previous studies (Appendix A) [52]. 
Due to the likely metal contamination of the species with the EDTA moiety, the protocol 
for adding the metals was altered in future modifications: a Chelex-100 column was used to 
remove trace metal contaminants from the water used to suspended EPD. In preparation for RNA 
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footprinting experiments, suspended EPD was then mixed with Fe3+  and reacted with the single-
cysteine RPP29 mutants. RNA footprinting assays were then conducted with modified RPP29 
mutants prepared with this new protocol. Currently, this modification protocol is also being used 
with other RPPs [Lai, Lai, Foster and Gopalan, unpublished]. 
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CONCLUSION 
 
A technique for the modification of cysteine residues with an EDTA moiety and chelated 
metal has successfully been implemented with the Pfu RPP29 protein. Modification of the 
RPP29 mutants was verified in multiple ways and used to chelate multiple metals to cysteine 
residues via an EDTA moiety from EPD. PRE NMR experiments were performed and used to 
detect residues on K88C that are close to the chelated Mn2+. Residues 86-89 and 91 were found 
to be closest to the paramagnetic probe, which was expected because the EDTA moiety was 
attached to residue 88. Therefore, these experiments also provided verification that the structural 
probe was attached to the desired protein residue. Moreover, RPP29 footprints from RPR 
cleavage assays were mapped to regions of the RPR that were previously predicted to bind 
RPP29. These metal chelation techniques, if applied to multiple cysteine residues on multiple 
subunits of Pfu RNase P, could be used to obtain numerous distance restraints that could lead to 
the development of a three-dimensional, atomic-resolution model of the Pfu RNase P 
holoenzyme. 
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APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A. In these overlaid 15N-HSQC spectra, the same [U-15N]-K88C-EDTA sample 
before and after a 16-day time period is depicted in blue and pink, respectively. The sample was 
stored at 4 °C during those 16 days. This relatively fast degradation of EPD-modified protein is 
consistent with previous studies [52]. 
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FIGURES 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. EPD enables the attachment of an EDTA moiety to a cysteine thiol group and 2-
pyridylthiol is produced as the leaving group. The RPP-EDTA species can then chelate an array 
of multivalent transition metals. Figure adapted from reference [28]. If fully extended, the length 
of the EDTA moiety from the cysteine’s α carbon to the metal ion is 14 Å [53]. 
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Figure 2. Ellman’s reagent quantifies free thiol concentrations: DTNB reacts with thiol groups, 
such as that attached to the β carbon of cysteine residues. The production of TNB can be 
monitored at 412 nm and is related to the concentration of free thiol groups by a 1:1 ratio 
(assuming there are no reducing agents in the assay). Figure adapted from reference [43]. 
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  (B) 
Figure 3. Purification of 15N-labeled K88C protein for NMR 
experiments with a 5-mL SP column. (A) In this FPLC 
chromatogram, the green curve represents the volume percent of 
Buffer B that is in the column. About half of the protein has 
eluted by the time the [KCl] reaches 300 mM, which is around 
14 % Buffer B. The blue curve represents the UV absorbance at 
280 nm of the eluting material from the column, and the dashed, 
red line segments delineate the different eluate fractions; 
fractions 11-13 contained the K88C protein. (B) In this 4-20 % 
Tris-HCl SDS-PAGE gel (Bio-Rad, stained with Coomassie 
Brilliant Blue dye), lane one is the SP column load-on, lane two 
is the SP column flow-through, lane three is fraction five from 
the FPLC run, lane four is combined fractions 11-13 from the 
FPLC run, and lane five is the SeeBlue Plus2 Pre-Stained 
Standard protein ladder. 
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Table 1. Ellman’s reagent quantifies the extent of EPD modification of K88C. 
 
 
 
 
Quantification of [K88C] was performed (by two methods) before and after EPD modification. 
The protein’s predicted extinction coefficient of 37,470 M-1cm-1 at 280 nm [41] was used in 
conjunction with an Ellman’s reagent assay that monitored the production of TNB, whose 
extinction coefficient at 412 nm is 14,150 M-1cm-1. Absorbance readings at 280 nm were first 
blanked with a buffer with 20 mM phosphate, 6 M guanidine-HCl, and pH 6.5. 40 uL of the 
unmodified K88C sample was combined with 960 uL of the buffer used for the blank and the 
absorbance at 280 nm was measured. Ellman’s reagent was used to determine the concentration 
of free thiol species according to the protocol in [54] (except the reaction buffer was 10 mM 
KCl, 10 mM Tris, pH 8.0). Both methods of quantification calculated similar [K88C] 
concentrations before modification. The same set of experiments was performed after EPD 
modification. This time, the calculated concentration of K88C from Ellman’s reagent was much 
lower than the calculated K88C concentration from the protein extinction coefficient. Note that 
the PD-10’s diluting factor of 5/7 accounts for the decrease in calculated K88C concentration by 
the A280 method. The difference in the calculated K88C concentrations after EPD modification 
suggests that 0.146/0.148 = 98.6 % of the cysteine residues have been modified by EPD. 
 
 
 
 
 
 
 
 
 
 
Quantification 
Method 
Absorbance 
Before 
Modification 
Calculated 
[K88C] Before 
Modification 
Absorbance 
After 
Modification 
Calculated 
[K88C] after 
Modification 
Extinction (A280) 0.313 0.209 mM 0.221 0.148 mM 
Ellman’s (A412) 0.262 0.208 mM 0.003 0.002 mM 
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Figure 4. Analysis of K88C and its derivatives by an Orbitrap ESI-mass spectrometer. (A) 
K88C: the expected average mass of this species is 14,896.1 Daltons (Da); the +43 Da mass shift 
from the anticipated 14,895.95 Da peak to the 14,938.95 Da peak is consistent with lysine 
carbamylation, which is commonly observed if old or heated urea stocks have been used in 
protein purifications [47-49]. (B) K88C-EDTA: the expected average mass of this species is 
15,245.5 Da. Peaks other than the anticipated one could result from a combination of lysine 
carbamylation and metal contamination, as EDTA is capable of binding many transition metals 
with a mass around 55 Da. (C) K88C-EDTA-Mn2+: the expected average mass of this species is 
15,297.4 Da. As with the K88C and K88C-EDTA species, the second major peak could be the 
result of lysine carbamylation.
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Figure 5. Overlaid 1H-15N HSQC spectra of wild type [U-15N] RPP29 [46] and the [U-15N]-
C94A RPP29 mutant [Xu and Foster, unpublished]. (A) The wild type spectrum is red, while the 
spectrum for the C94A mutant is orange. Spectral assignments are for peaks in the spectrum of 
the C94A mutant. 
 
 
 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Overlaid 1H-15N HSQC spectra of the [U-15N]-C94A RPP29 mutant [Xu and Foster, 
unpublished] and the [U-15N]-K88C/C94A RPP29 mutant. (A) The spectrum of the C94A 
mutant is orange, while the spectrum of the K88C/C94A mutant is green. 
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Figure 7. Overlaid 1H-15N HSQC spectra of the [U-15N]-K88C/C94A RPP29 mutant and the [U-
15N]-K88C/C94A-EDTA species. (A) The spectrum of the [U-15N]-K88C/C94A mutant is green, 
while the spectrum of the [U-15N]-K88C/C94A-EDTA species is blue. 
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Figure 8. Overlaid 1H-15N HSQC spectra of the [U-15N]-K88C/C94A-EDTA species and the [U-
15N]-K88C/C94A-EDTA-Mn2+ species. (A) The spectrum of the [U-15N]-K88C/C94A-EDTA 
species is blue, while the spectrum of the [U-15N]-K88C/C94A-EDTA-Mn2+ species is red. PRE 
is indicated by peaks in the pink spectrum that have partially or completely disappeared in the 
purple spectrum, as highlighted by the green arrows. 
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Figure 9. Mapping the effects of PRE to the structure of Pfu RPP29. (A) Green spheres indicate 
the protein residues that showed the largest response to the introduction of the paramagnetic 
Mn2+ probe: V64, Y63, T74, V86, W87, V89, and K91. Residue 88, the site of the attachment of 
the EDTA moiety, is indicated by the orange sphere. 
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(B) 
Figure 10. Purification of unlabeled K88C 
protein for RNA footprinting experiments.  
 
(A) In this FPLC chromatogram, the green 
curve represents the volume percent of Buffer B 
that is in the column. About half of the protein 
has eluted by the time the [KCl] reaches 300 
mM, which is around 14 % Buffer B. The blue 
curve represents the UV absorbance at 280 nm 
of the eluting material from the column, and the 
dashed red line segments delineate the different 
eluate fractions; fractions 12-14 contained the 
K88C protein.  
 
(B) In this 4-20 % Tris-HCl SDS-PAGE gel (stained with Coomassie Brilliant Blue dye), lane one is 
K88C before induction, lane two is induced K88C, lane three is the pellet form the first 
centrifugation step, lane four is the soluble fraction from the first centrifugation step, lane five is the 
pellet from the second centrifugation step, lane six is the soluble fraction from the second 
centrifugation step, lane seven is the SP column flow-through, lane eight is fraction 8 (from the 
FPLC run), lane nine is the SeeBlue Plus2 Pre-Stained Standard protein ladder, and lanes A-E 
correspond to fractions 11-15, respectively. The data from the chromatogram and the gel suggest that 
relatively pure K88C was successfully purified. 
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Figure 11. MALDI mass spectra confirm the EPD-Fe modification of the K88C protein. (A) 
K88C: in this mass spectrum, the expected mass/charge ratios (in Da/elementary charge) of the 
(z = +1), (z = +2), and (z = +3) states were 14,897.1, 7,749.05, and 4,966.36, respectively. 
Furthermore, the expected mass/charge ratio for the (z = +3) state of the protein dimer was 
9,931.06. (B) K88C-EDTA-Fe: in this mass spectrum, the expected mass/charge ratios of the (z 
= +1), (z = +2), and (z = +3) states were 15,303.3, 7,652.2, and 5,101.8, respectively. Moreover, 
the expected mass/charge ratio for the (z = +3) state of the protein dimer was 10,202.5. 
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Figure 12. RNA footprinting products subjected to polyacrylamide gel electrophoresis and 
autoradiography. [Lai, Foster and Gopalan, unpublished]. (A) The first four lanes contain 32P-
labeled, dideoxynucleoside triphosphates (ddNTPs) of the indicated base (thymine, guanine, 
cytosine, and adenine, respectively) as well as unlabeled NTPs. These lengths report on the 
specific sites of the RNA cleavage, and cleavage sites for the R75C-EDTA-Fe and K88C-EDTA-
Fe species are depicted by purple circles and green stars, respectively. 
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Figure 13. RNA footprinting cleavage sites mapped to the RPR structure. (A) In this two-
dimensional representation of the Pfu RPR [Lai, Foster and Gopalan, unpublished], cleavage 
sites from R75C-EDTA-Fe and K88C-EDTA-Fe are represented by purple circles and green 
stars, respectively. (B) In this three-dimensional model of the Pfu RPR [Crowe and Foster, 
unpublished], hydroxyl-radical cleavage sites from R75C-EDTA-Fe and K88C-EDTA-Fe are 
represented by purple spheres and green spheres, respectively. 
